Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Bonnie Ky"'
Autor:
Justin C. Brown, Andrea B. Troxel, Michael R. Rickels, Anil K. Rustgi, Kathryn H. Schmitz, Nevena Damjanov, Babette S. Zemel, Bonnie Ky, Andrew D. Rhim, Kerry S. Courneya
Publikováno v:
Endocrine-Related Cancer. 25:11-19
Physical activity is associated with a lower risk of disease recurrence among colon cancer survivors. The pathways through which physical activity may alter disease outcomes are unknown, but may include changes in metabolic growth factors, such as in
Autor:
Martin S. Tallman, James M. Foran, Jonathan Canaani, Bonnie Ky, Vera H. Rigolin, Jessica K. Altman, Woo Bin Voss, Nausheen Akhter, Selina M. Luger, Gregory Cascino, Nicholas Furiasse, Alfred Rademaker, Mark R. Litzow
Publikováno v:
Echocardiography
Background: Patients with acute myeloid leukemia (AML) are surviving longer. There are no data on changes in myocardial mechanics from standard of care low-dose anthracycline-based induction chemotherapy in older patients with AML. The aim of this st
Autor:
Le Wang, Bonnie Ky, Anupam Basuray, Nancy K. Sweitzer, Thomas P. Cappola, Benjamin French, James C. Fang, Jeffrey Brandimarto
Publikováno v:
Journal of Cardiac Failure. 22:256-262
Clinical studies have suggested the prognostic value of galectin-3, a marker of fibrosis, in chronic heart failure. However, the specific role of galectin-3, compared with established biomarkers, remains uncertain.The Penn Heart Failure Study was an
Autor:
Bonnie Ky, Nancy K. Sweitzer, Lee R. Goldberg, Thomas P. Cappola, Wayne C. Levy, Benjamin French, James C. Fang, Mariell Jessup, Alan H.B. Wu
Publikováno v:
Circulation: Heart Failure. 5:183-190
Background— Prior studies have suggested using a panel of biomarkers that measure diverse biological processes as a prognostic tool in chronic heart failure. Whether this approach improves risk prediction beyond clinical evaluation is unknown. Meth
Autor:
Thomas P. Cappola, Stephen E. Kimmel, Nancy K. Sweitzer, Bonnie Ky, Mary E. Putt, James C. Fang, Douglas B. Sawyer, Radwan Safa
Publikováno v:
Circulation. 120:310-317
Background— Neuregulin-1 (NRG-1) is a paracrine factor released by microvascular endothelial cells that has cardioprotective effects in animal models of heart failure. However, circulating NRG-1 has not been studied in human heart disease. We used